Arca
Skip to content
Tools
Tools

CACNA2D1: Voltage-dependent calcium channel subunit alpha-2/delta-1

The alpha-2/delta subunit of voltage-dependent calcium channels regulates calcium current density and activation/inactivation kinetics of the calcium channel.

  • Drugs that act on it: 1
  • Approved: 0
  • In phases 1 to 3: 1
  • Sponsors: 1

Who is on it, and how far along

Every drug ChEMBL records acting on CACNA2D1, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 1

Approved0

    Phase 31

    • Mirogabalin

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        DrugFurthest stageSponsorModalityActionOpen trials
        MirogabalinPhase 3Daiichi SankyoSmall moleculeModulatorVoltage-gated calcium channel alpha2/delta subunit 1 modulator8

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 8 in all, from ClinicalTrials.gov.
        Mirogabalin vs. Melatonin for Pain and Anxiety After Total Knee Arthroplasty Under Spinal AnesthesiaMirogabalinPhase 3Not yet recruitingBeni-Suef UniversityNov 20, 2026
        Efficacy and Safety of Mirogabalin in Uremic PruritusMirogabalinPhase 2Not yet recruitingAlexandria UniversityNov 13, 2026
        Perioperative Mirogabalin for Pain Relief After Modified Radical MastectomyMirogabalinNot applicableNot yet recruitingCairo UniversityOct 19, 2026
        Mirogabalin Plus EBMP for IC/BPSMirogabalinPhase 1Not yet recruitingBeijing Tiantan HospitalSep 3, 2026
        Efficacy and Safety of Mirogabalin in Diabetic Peripheral Neuropathic PainMirogabalinPhase 4RecruitingBangladesh Medical UniversityMar 5, 2026
        The Analgesic Efficacy and Safety of Mirogabalin in Patients With Herpes ZosterMirogabalinNot applicableRecruitingBeijing Tiantan HospitalDec 29, 2025
        The Efficacy and Safety of Pregabalin and Mirogabalin in Patients With FibromyalgiaMirogabalinNot applicableRecruitingBeijing Tiantan HospitalSep 5, 2025
        Comparing Efficiency of Mirogabalin and Pregabalin in Primary TKAMirogabalinNot applicableRecruitingThammasat University HospitalMar 25, 2024

        Diseases most associated with it

        Open Targets association score, 0 to 1; all associations
        • Seizure0.69
        • Focal-onset seizure0.52
        • Developmental and epileptic encephalopathy 1100.49
        • Cardiovascular disorder0.49

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL1919, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. Gene name, function (UniProt P54289, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.